Voluntary and Mandatory Prepayments. Scheduled installments of principal of the Series C Tranche B Term Loans set forth above shall be reduced in connection with any voluntary or mandatory prepayments of the Series C Tranche B Term Loans in accordance with Sections 2.12, 2.13 and 2.14 of the Credit Agreement respectively.
Appears in 1 contract
Samples: Joinder Agreement (Valeant Pharmaceuticals International, Inc.)
Voluntary and Mandatory Prepayments. Scheduled installments of principal of the Series C E-1 Tranche B Term Loans set forth above shall be reduced in connection with any voluntary or mandatory prepayments of the Series C E-1 Tranche B Term Loans in accordance with Sections 2.12, 2.13 and 2.14 of the Credit Agreement respectively.
Appears in 1 contract
Samples: Joinder Agreement (Valeant Pharmaceuticals International, Inc.)
Voluntary and Mandatory Prepayments. Scheduled installments of principal of the Series C D Tranche B Term Loans set forth above shall be reduced in connection with any voluntary or mandatory prepayments of the Series C D Tranche B Term Loans in accordance with Sections 2.12, 2.13 and 2.14 of the Credit Agreement respectively.
Appears in 1 contract
Samples: Joinder Agreement (Valeant Pharmaceuticals International, Inc.)
Voluntary and Mandatory Prepayments. Scheduled installments of principal of the Series C E Tranche B Term Loans set forth above shall be reduced in connection with any voluntary or mandatory prepayments of the Series C E Tranche B Term Loans in accordance with Sections 2.12, 2.13 and 2.14 of the Credit Agreement respectively.
Appears in 1 contract
Samples: Joinder Agreement (Valeant Pharmaceuticals International, Inc.)
Voluntary and Mandatory Prepayments. Scheduled installments of principal of the Series C B Tranche B Term Loans set forth above shall be reduced in connection with any voluntary or mandatory prepayments of the Series C B Tranche B Term Loans in accordance with Sections 2.12, 2.13 and 2.14 of the Credit Agreement respectively.
Appears in 1 contract
Samples: Joinder Agreement (Valeant Pharmaceuticals International, Inc.)